Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks

Genome Medicine

Volumn 4, Issue 2, 2012, Pages

  Newman, Aaron M ^a,d   Gallo, Natasha B ^a   Hancox, Lisa S ^b   Miller, Norma J ^c   Radeke, Carolyn M ^a   Maloney, Michelle A ^a   Cooper, James B ^a   Hageman, Gregory S ^c   Anderson, Don H ^a   Johnson, Lincoln V ^a   Radeke, Monte J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT; PROTEIN; TRANSCRIPTOME;

ARTICLE; BIOINFORMATICS; CELLULAR IMMUNITY; CHOROID; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EYE; GENE FUNCTION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; NERVOUS SYSTEM DEVELOPMENT; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PHENOTYPE; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; TRANSCRIPTOMICS; WOUND HEALING;

EID: 85027939027     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm315     Document Type: Article

References (143)

1. Cohen LH, Noell WK. Relationships between visual function and metabolism. Biochemistry of the Retina 1965, 35-50. Orlando, FL: Academic Press Inc, Graymor CN.
2. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003, 121:547-557. 10.1001/archopht.121.4.547, 12695252.
3. Foulds WS. The choroidal circulation and retinal metabolism - an overview. Eye 1990, 4:243-248. 10.1038/eye.1990.35, 2379643.
4. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011, 129:75-80. 10.1001/archophthalmol.2010.318, 21220632.
5. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995, 39:367-374. 10.1016/S0039-6257(05)80092-X, 7604360.
6. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001, 20:705-732. 10.1016/S1350-9462(01)00010-6, 11587915.
7. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002, 134:411-431. 10.1016/S0002-9394(02)01624-0, 12208254.
8. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 2010, 128:349-358. 10.1001/archophthalmol.2010.18, 20212207.
9. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration- emerging pathogenetic and therapeutic concepts. Ann Med 2006, 38:450-471. 10.1080/07853890600946724, 17101537.
10. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010, 29:95-112. 10.1016/j.preteyeres.2009.11.003, 19961953.
11. Age-Related Eye Disease Study Research Group Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000, 107:2224-2232. 1470467, 11097601, Age-Related Eye Disease Study Research Group.
12. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119:1417-1436. 1462955, 11594942, Age-Related Eye Disease Study Research Group.
13. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001, 108:697-704. 10.1016/S0161-6420(00)00580-7, 11297486.
14. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang HH, Taylor HR. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthamol 2001, 119:1455-1462.
15. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424. 10.1126/science.1110189, 15761121.
16. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389. 10.1126/science.1109557, 1512523, 15761122.
17. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421. 10.1126/science.1110359, 15761120.
18. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005, 102:7227-7232. 10.1073/pnas.0501536102, 1088171, 15870199.
19. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, , Hageman GS, Dean M, Allikmets R. AMD Genetics Clinical Study Group Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006, 38:458-462. 10.1038/ng1750, 2921703, 16518403, AMD Genetics Clinical Study Group.
20. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M, . AMD Clinical Study Group Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 2006, 38:592-604. 10.1080/07853890601097030, 1905836, 17438673, AMD Clinical Study Group.
21. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT, . Genetic Factors in AMD Study Group Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007, 357:553-561. 10.1056/NEJMoa072618, 17634448, Genetic Factors in AMD Study Group.
22. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007, 39:1200-1201. 10.1038/ng2131, 17767156.
23. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005, 77:389-407. 10.1086/444437, 1226205, 16080115.
24. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Weber BH. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005, 14:3227-3236. 10.1093/hmg/ddi353, 16174643.
25. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807, 17053108.
26. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811, 17053109.
27. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane G. The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998, 125:353-359. 10.1016/S0002-9394(99)80146-9, 9512153.
28. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, van Broeckhoven C, de Jong PT. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998, 63:200-206. 10.1086/301901, 1377225, 9634502.
29. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The ε2 and ε4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004, 45:1311-1315. 10.1167/iovs.03-1121, 15111582.
30. Zareparsi S, Reddick AC, Branham KE, Moore KB, Jessup L, Thoms S, Smith-Wheelock M, Yashar BM, Swaroop A. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004, 45:1306-1310. 10.1167/iovs.03-1253, 15111581.
31. Fritsche LG, Freitag-Wolf S, Bettecken T, Meitinger T, Keilhauer CN, Krawczak M, Weber BH. Age-related macular degeneration and functional promoter and coding variants of the apolipoprtoein E gene. Hum Mutat 2009, 30:1048-1053. 10.1002/humu.20957, 19384966.
32. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, , Brucker AJ, Orlin A, Brown G, Ho A, et al. Complications of Age-Related Macular Degeneration Prevention Trial Research Group Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010, 107:7401-7406. 10.1073/pnas.0912702107, 2867722, 20385819, Complications of Age-Related Macular Degeneration Prevention Trial Research Group.
33. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010, 107:7395-7400. 10.1073/pnas.0912019107, 2867697, 20385826.
34. Munro KM, Perreau VM. Current and future applications of transcriptomics for discovery in CNS disease and injury. Neurosignals 2009, 17:311-327. 10.1159/000231897, 19816067.
35. Edelman LB, Eddy JA, Price ND. In silico models of cancer. Wiley Interdiscip Rev Syst Biol Med 2010, 2:438-459. 3157287, 20836040.
36. Radeke MJ, Peterson KE, Johnson LV, Anderson DH. Disease susceptibility of the human macula: differential gene transcription in the retinal pigmented epithelium/choroid. Exp Eye Res 2007, 85:366-380. 10.1016/j.exer.2007.05.006, 17662275.
37. van Soest SS, de Wit GM, Essing AH, ten Brink JB, Kamphuis W, de Jong PT, Bergen AA. Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. Mol Vis 2007, 13:1608-1617.
38. Booij JC, ten Brink JB, Swagemakers SM, Verkerk AJ, Essing AH, van der Spek PJ, Bergen AA. A new strategy to identify and annotate human RPE-specific gene expression. PLoS ONE 2010, 5:e9341. 10.1371/journal.pone.0009341, 2866542, 20479888.
39. Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, Swaroop A, Munson PJ, Miller SS. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet 2010, 19:2468-2486. 10.1093/hmg/ddq129, 2876890, 20360305.
40. Lederman M, Weiss A, Chowers I. Association of neovascular age-related macular degeneration with specific gene expression patterns in peripheral white blood cells. Invest Ophthalmol Vis Sci 2010, 51:53-58. 10.1167/iovs.08-3019, 19684010.
41. van Leeuwen R, Klaver CC, Vingerling JR, Hoffman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003, 121:519-526. 10.1001/archopht.121.4.519, 12695249.
42. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001, 132:668-681. Age-Related Eye Disease Study Research Group.
43. Fisher RA, Yates F. Statistical Tables for Biological, Agricultural and Medical Research. 1948, Oliver and Boyd, London, England: Hafner Press.
44. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100:9440-9445. 10.1073/pnas.1530509100, 170937, 12883005.
45. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
46. Newman AM, Cooper JB. AutoSOME: a clustering method for identifying gene expression modules without prior knowledge of cluster number. BMC Bioinformatics 2010, 11:117. 10.1186/1471-2105-11-117, 2846907, 20202218.
47. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nat Genet 2006, 38:500-501. 10.1038/ng0506-500, 16642009.
48. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 2002, 9:505-511. 10.1089/106652702760138592, 12162889.
49. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:D412-D416. 10.1093/nar/gkn760, 2686466, 18940858.
50. Bossi A, Lehner B. Tissue specificity and the human protein interaction network. Mol Syst Biol 2009, 5:260. 2683721, 19357639.
51. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009, 37:W305-W311. 10.1093/nar/gkp427, 2703978, 19465376.
52. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13. 10.1093/nar/gkn923, 2615629, 19033363.
53. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504. 10.1101/gr.1239303, 403769, 14597658.
54. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997, 277:1805-1807. 10.1126/science.277.5333.1805, 9295268.
55. Hamdi HK, Reznik J, Castellon R, Atilano SR, Ong JM, Udar N, Tavis JH, Aoki AM, Nesburn AB, Boyer DS, Small KW, Brown DJ, Kenney MC. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun 2002, 295:668-672. 10.1016/S0006-291X(02)00728-3, 12099691.
56. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002, 99:14682-14687. 10.1073/pnas.222551899, 137479, 12391305.
57. Yuan X, Gu X, Crabb JS, Yue X, Shadrach K, Hollyfield JG, Crabb JW. Quantitative proteomics: comparison of the macular bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics 2010, 9:1031-1046. 10.1074/mcp.M900523-MCP200, 2877969, 20177130.
58. Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA. Abundant lipid and protein components of drusen. PLoS ONE 2010, 5:e10329. 10.1371/journal.pone.0010329, 2859054, 20428236.
59. Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006, 47:2280-2290. 10.1167/iovs.05-1395, 16723435.
60. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:2848-2855. 10.1167/iovs.07-1352, 18344451.
61. Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006, 47:815-822. 10.1167/iovs.05-0976, 16505012.
62. An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, Strunnikova N, Csaky K, Hathout Y. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 2006, 5:2599-2610. 10.1021/pr060121j, 17022631.
63. Mo FM, Proia AD, Hohnson WH, Cyr D, Lashkari K. Interferon γ-inducible protein-10 and eotaxin as biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:4226-4236. 10.1167/iovs.09-3910, 20220052.
64. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 2010, 128:1281-1286. 10.1001/archophthalmol.2010.227, 20937997.
65. Guymer RH, Tao LW, Goh JK, Liew D, Ischenko O, Robman LD, Aung K, Cipriani T, Cain M, Richardson AJ, Baird PN, Langham R. Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci 2011, 52:4639-4644. 10.1167/iovs.10-7120, 21498607.
66. Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol 2008, 92:976-980. 10.1136/bjo.2007.129742, 18577650.
67. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009, 17:100-104. 10.1038/ejhg.2008.140, 2985963, 18685559.
68. Newsome DA, Swartz M, Leone NC, Hewitt AT, Wolford F, Miller ED. Macular degeneration and elevated serum ceruloplasmin. Invest Ophthalmol Vis Sci 1986, 27:1675-1680.
69. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005, 112:2076-2080. 10.1016/j.ophtha.2005.07.004, 16225921.
70. Boekhoorn SS, Vingerling HR, Witteman JC, Hofman A, de Jong PT. C-reactive protein level and risk of aging macula disorder: Rotterdam Study. Arch Ophthalmol 2007, 125:1396-1401. 10.1001/archopht.125.10.1396, 17923549.
71. Klein R, Knudtson MD, Klein BE, Wong TY, Cotch MF, Liu K, Cheng CY, Burke GL, Saad MF, Jacobs DR, Sharrett AR. Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology 2008, 115:1742-1749. 10.1016/j.ophtha.2008.03.021, 2936447, 18538409.
72. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005, 123:774-782. 10.1001/archopht.123.6.774, 15955978.
73. Zurdel J, Finckh U, Menxer G, Nitsch RM, Richard G. CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol 2002, 86:214-219. 10.1136/bjo.86.2.214, 1771004, 11815350.
74. Klein R, Knudtson MD, Lee KE, Klein BE. Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2009, 127:193-199. 10.1001/archophthalmol.2008.551, 2737458, 19204238.
75. He S, Jin ML, Worpel V, Hinton DR. A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch Ophthalmol 2003, 121:1283-1288. 10.1001/archopht.121.9.1283, 12963611.
76. Watanabe D, Takagi H, Suzuma K, Oh H, Ohashi H, Honda Y. Expression of connective tissue growth factor and its potential role in choroidal neovascularization. Retina 2005, 25:911-918. 10.1097/00006982-200510000-00015, 16205572.
77. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG, Chew EY, Chan CC. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004, 18:1297-1299. 1971128, 15208270.
78. Machalinska A, Safranow K, Dziedziejko V, Mozolewska-Piotrowska K, Paczkowska E, Klos P, Pius E, Grymula K, Wiszniewska B, Karczewicz D, Machalinski B. Different populations of circulating endothelial cells in patients with age-related macular degeneration: novel insight into pathogenesis. Invest Ophthalmol Vis Sci 2011, 52:93-100. 10.1167/iovs.10-5756, 20720219.
79. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG, Kleinman ME, Ponicsan SL, Hauswirth WW, Chiodo VA, Karikó K, Yoo JW, Lee DK, Hadziahmetovic M, Song Y, Misra S, Chaudhuri G, Buaas FW, Braun RE, Hinton DR, Zhang Q, Grossniklaus HE, Provis JM, Madigan MC, Milam AH, Justice NL, Albuquerque RJ, Blandford AD, Bogdanovich S, Hirano Y, et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011, 471:325-330. 10.1038/nature09830, 3077055, 21297615.
80. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular dgeneration. Am J Ophthalmol 2000, 130:769-773. 10.1016/S0002-9394(00)00552-3, 11124296.
81. Tuo J, Ning B, Bojanowski CM, Lin ZN, Ross RJ, Reed GF, Shen D, Jiao X, Zhou M, Chew EY, Kadlubar FF, Chan CC. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci USA 2006, 103:9256-9261. 10.1073/pnas.0603485103, 1474016, 16754848.
82. Jiang S, Moriarty-Craige SE, Li C, Lynn MJ, Cai J, Jones DP, Sternberg P. Associations of plasma-soluble fas ligand with aging and age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49:1345-1349. 10.1167/iovs.07-0308, 18385048.
83. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA, Eastman CG, Casavant TL, Sheffield VC. Missense variations in the fibulin 5 and age-related macular degeneration. N Engl J Med 2004, 351:346-353. 10.1056/NEJMoa040833, 15269314.
84. Lip PL, Blann AD, Hope-Ross M, Givson HM, Lip GY. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 2001, 108:705-710. 10.1016/S0161-6420(00)00663-1, 11297487.
85. Oz O, Aras Ates N, Tamer L, Yeldirim O, Adigüzel U. Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Eur J Ophthalmol 2006, 16:105-110.
86. Güven M, Görgün E, Unal M, Yenerel M, Batar B, Küçümen B, Dinç UA, Güven GS, Ulus T, Yüksel A. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res 2011, 46:31-37. 10.1159/000321940, 21212706.
87. Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D. Expression of hypoxia-inducible factor-1α and -2α in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 2009, 247:1361-1367. 10.1007/s00417-009-1133-3, 19590888.
88. Goverdhan SV, Howell MW, Mullins RF, Osmond C, Hodgkins PR, Self J, Avery K, Lotery AJ. Association of HLA class I and class II polymorphism with age-related macular degeneration. Invest Ophthalmol Vis Sci 2005, 46:1726-1734. 10.1167/iovs.04-0928, 15851575.
89. Schultz DW, Klein ML, Humpert AJ, Luzier CW, Persun V, Schain M, Mahan A, Runckel C, Cassera M, Vittal V, Doyle TM, Martin TM, Weleber RG, Francis PJ, Acott TS. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 2003, 12:3315-3323. 10.1093/hmg/ddg348, 14570714.
90. Frank RN, Amin RH, Puklin JE. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. Am J Ophthalmol 1999, 127:694-709. 10.1016/S0002-9394(99)00032-X, 10372880.
91. Wu KH, Tan AG, Rochtchina E, Favaloro EJ, Williams A, Mitchell P, Wang JJ. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study. Invest Ophthalmol Vis Sci 2007, 48:1983-1988. 10.1167/iovs.06-0223, 17460250.
92. Goverdhan SV, Ennis S, Hannan SR, Madhusudhana KC, Cree AJ, Luff AJ, Lotery AJ. Interleukin-8 promoter polymorphisms -251A/T is a risk factor for age-related macular degeneration. Br J Ophthalmol 2008, 92:537-540. 10.1136/bjo.2007.123190, 18310311.
93. Evereklioglu C, Doganay S, Er H, Cekmen M, Ozerol E, Otlu B. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: a preliminary study. Eye 2003, 17:350-355. 10.1038/sj.eye.6700345, 12724698.
94. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006, 47:329-335. 10.1167/iovs.05-0116, 16384981.
95. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998, 39:2194-2200.
96. Fiotti N, Pedio M, Battaglia Parodi M, Altamura N, Uxa L, Guarnieri G, Giansante C, Ravalico G. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genet Med 2005, 7:272-277. 10.1097/01.GIM.0000159903.69597.73, 15834245.
97. Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye 2008, 22:855-859. 10.1038/sj.eye.6702722, 18597988.
98. Bhutto IA, Baba T, Merges C, McLeod DS, Lutty GA. Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp Eye Res 2010, 90:155-167. 10.1016/j.exer.2009.10.004, 2789190, 19836390.
99. Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol 2010, 94:918-925. 10.1136/bjo.2009.165563, 19965817.
100. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumi K, Kinoshita S. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein levels as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 2001, 132:191-195. 10.1016/S0002-9394(01)00975-8, 11476678.
101. Ethen CM, Feng X, Olsen TW, Ferrington DA. Declines in arrestin and rhodopsin in the macula with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 2005, 46:769-775. 10.1167/iovs.04-0810, 15728529.
102. Zerbib J, Seddon JM, Richard F, Reynolds R, Leveziel N, Benlian P, Borel P, Feingold J, Munnich A, Soubrane G, Kaplan J, Rozet JM, Souied EH. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 2009, 4:e7341. 10.1371/journal.pone.0007341, 2752725, 19806217.
103. Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tseng SH, Tsai FJ. Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration. Am J Ophthalmol 2008, 145:716-721. 10.1016/j.ajo.2007.11.006, 18226801.
104. Holekamp NM, Bouck N, Volpert O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 2002, 134:220-227. 10.1016/S0002-9394(02)01549-0, 12140029.
105. Ennis S, Jomary C, Mullins R, Cree A, Chen X, Macleod A, Jones S, Collins A, Stone E, Lotery A. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 2008, 372:1828-1834. 10.1016/S0140-6736(08)61348-3, 18842294.
106. Wysokinski D, Szaflik J, Sklodowska A, Kolodziejska U, Dorecka M, Romaniuk D, Wozniak K, Blasiak J, Szaflik JP. The A allele of the -576 G > A polymorphism of the transferrin gene is associated with the increased risk of age-related macular degeneration in smokers. Tohoku J Exp Med 2011, 223:253-261. 10.1620/tjem.223.253, 21422745.
107. Yang Z, Stratton C, Francis PJ, Kleinman ME, Tan PL, Gibbs D, Tong Z, Chen H, Constantine R, Yang X, Chen Y, Zeng J, Davey L, Ma X, Hau VS, Wang C, Harmon J, Buehler J, Pearson E, Patel S, Kaminoh Y, Watkins S, Luo L, Zabriskie NA, Bernstein PS, Cho W, Schwager A, Hinton DR, Klein ML, Hamon SC, Simmons E, Yu B, Campochiaro B, Sunness JS, Campochiaro P, Jorde L, Parmigiani G, Zack DJ, Katsanis N, Ambati J, Zhang K. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med 2008, 359:1456-1463. 10.1056/NEJMoa0802437, 2573951, 18753640.
108. Zareparsi S, Buraczynska M, Branham KE, Shah S, Eng D, Li M, Pawar H, Yashar BM, Moroi SE, Lichter PR, Petty HR, Richards JE, Abecasis GR, Elner VM, Swaroop A. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005, 14:1449-1455. 10.1093/hmg/ddi154, 15829498.
109. Tolppanen AM, Nevalainen T, Kolehmainen M, Seitsonen S, Immonen I, Uusitupa M, Kaarniranta K, Pulkkinen L. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol Vis 2009, 15:762-770. 2669446, 19381347.
110. Churchill AJ, Carter JG, Lovell HC, Ramsden C, Turner SJ, Yeung A, Escardo J, Atan D. VEGF polymorphisms are associated with neovascular age-related macular degenration. Hum Mol Genet 2006, 15:2955-2961. 10.1093/hmg/ddl238, 16940309.
111. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Opthalmology 2007, 99:933-943.
112. Munch IC, Sander B, Kessel L, Hougaard JL, Taarnhøj NC, Sørenson TI, Kyvik KO, Larsen M. Heredity of small hard drusen in twins aged 20-46 years. Invest Ophthalmol Vis Sci 2007, 48:833-838. 10.1167/iovs.06-0529, 17251485.
113. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Opthalmology 2007, 114:253-262.
114. Munch IC, Ek J, Kessel L, Sander S, Almind GJ, Brøndum-Nielsen K, Linneberg A, Larsen M. Small hard macular drusen and peripheral drusen: Associations with AMD Genotypes in the Inter99 Eye Study. Invest Ophthalmol Vis Sci 2010, 51:2317-2321. 10.1167/iovs.09-4482, 20007824.
115. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
116. Chowers I, Gunatilaka TL, Farkas RH, Qian J, Hackam AS, Duh E, Kageyama M, Wang C, Vora A, Campochiaro PA, Zack DJ. Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray. Invest Ophthalmol Vis Sci 2003, 44:3732-3741. 10.1167/iovs.02-1080, 12939286.
117. Day A, Carlson MR, Dong J, O'Connor BD, Nelson SF. Celsius: a community resource for Affymetrix microarray data. Genome Biol 2007, 8:R112. 10.1186/gb-2007-8-6-r112, 2394754, 17570842.
118. Müller M, Carter S, Hofer MJ, Campbell IL. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum. Neuropathol Appl Neurobiol 2010, 36:368-387. 10.1111/j.1365-2990.2010.01089.x, 20487305.
119. Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004, 36:1090-1098. 10.1038/ng1434, 15448693.
120. Gerlini G, Hefti HP, Kleinhans M, Nickoloff BJ, Burg G, Nestle FO. Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol 2001, 117:576-582. 10.1046/j.0022-202x.2001.01458.x, 11564162.
121. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994, 180:1841-1847. 10.1084/jem.180.5.1841, 2191743, 7525840.
122. Maeda A, Crabb JW, Palczewski K. Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry 2005, 44:480-489. 10.1021/bi048016f, 1351247, 15641772.
123. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 2002, 120:1435-1442.
124. Johnson PT, Brown MN, Pulliam BC, Anderson DH, Johnson LV. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthalmol Vis Sci 2005, 46:4788-4795. 10.1167/iovs.05-0767, 16303980.
125. Viola A, Luster AD. Chemokines and their receptors: Drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008, 48:171-197. 10.1146/annurev.pharmtox.48.121806.154841, 17883327.
126. Shi G, Maminishkis A, Banzon T, Jalickee S, Li R, Hammer J, Miller SS. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008, 49:4620-4630. 10.1167/iovs.08-1816, 2574653, 18450597.
127. Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005, 26:136-140. 10.1016/j.it.2004.12.006, 15745855.
128. Yasuda Y, Li Z, Greenbaum D, Bogyo M, Weber E, Brömme D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 2004, 279:36761-36770. 10.1074/jbc.M403986200, 15192101.
129. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000, 70:441-449. 10.1006/exer.1999.0798, 10865992.
130. Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003, 278:42027-42035. 10.1074/jbc.M305460200, 12923198.
131. Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1990, 228:270-274. 10.1007/BF00920033, 2193850.
132. Patel N, Ohbayashi M, Nugent AK, Ramchand K, Toda M, Chau KY, Bunce C, Webster A, Bird AC, Ono SJ, Chong V. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005, 115:422-430. 10.1111/j.1365-2567.2005.02173.x, 1782158, 15946260.
133. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH. Analysis of IgG antibody patterns against retinal antigens and antibodies to α-crystallin, GFAP, and α-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007, 245:619-626. 10.1007/s00417-006-0429-9, 17058093.
134. Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol 2001, 75:9780-9789. 10.1128/JVI.75.20.9780-9789.2001, 114550, 11559811.
135. Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, Picard E, Debré P, Sirinyan M, Deterre P, Ferroukhi T, Cohen SY, Chauvaud D, Jeanny JC, Chemtob S, Behar-Cohen F, Sennlaub F. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007, 117:2920-2928. 10.1172/JCI31692, 1994614, 17909628.
136. Collier RJ, Wang Y, Smith SS, Martin E, Ornberg R, Rhoades K, Romano C. Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist. Invest Ophthalmol Vis Sci 2011, 52:8108-8116. 10.1167/iovs.10-6418, 21467172.
137. Rutar M, Natoli R, Kozulin P, Valter K, Gatenby P, Provis JM. Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 microglia/macrophages is associated with focal photoreceptor degeneration. Invest Ophthalmol Vis Sci 2011, 52:5347-5358. 10.1167/iovs.10-7119, 21571681.
138. Chao W, D'Amore PA. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008, 19:111-120. 10.1016/j.cytogfr.2008.01.005, 2314671, 18308616.
139. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009, 41:771-783. 10.1016/j.biocel.2008.07.025, 2668982, 18775791.
140. Fedarko NS, Fohr B, Robey PG, Young MF, Fisher LW. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 2000, 275:16666-16672. 10.1074/jbc.M001123200, 10747989.
141. Shijubo N, Uede T, Kon S, Nagata M, Abe S. Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncog 2000, 11:135-146.
142. Wang ZY, Shen LJ, Tu L, Hu DN, Liu GY, Zhou ZL, Lin Y, Chen LH, Qu J. Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radic Biol Med 2009, 46:1032-1041. 10.1016/j.freeradbiomed.2008.11.027, 19136057.
143. Leung KW, Barnstable CJ, Tombran-Tink J. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 an IL-8 autocrine signaling. Mol Immunol 2009, 46:1374-1386. 10.1016/j.molimm.2008.12.001, 19157552.